Fig. 6From: Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safetySafety of IRDye800CW. a A world map schematic showing the number of in-progress, completed, and withdrawn clinical trial with IRDye800CW. The map was produced using R Studio version 3.3.2 (https://www.r-project.org). b Diagram of indications tested in clinical trials with IRDye800CW. c Adverse events and grade level associated with IRDye800CW from clinical trial dataBack to article page